Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :12932653
Publication Date : //

Development of novel substrates for tumor immunotherapy.


Acid-terminated polyglycolide microparticles (PG-MP) were prepared as a versatile substrate that could be surface-modified for either immobilization of anti-cd3 and anti-cd28 mAb to activate T cells or sustained release of granulocyte-macrophage colony stimulating factor (GM-CSF) for dendritic cell (DC) recruitment and maturation. PG-MP were prepared with a volume-weighted mean diameter of 56 or 57 microm. Accessible carboxylic acid group concentration was determined by potentiometric titration to be 0.3 mmole/g and corresponded to a zeta potential of -21.87 mV. PG-MP immobilized with either anti-human CD3/CD28 or anti-mouse cd3/cd28 induced significant proliferation of T cells. Intracellular flow cytometry in activated mouse T cells was significant for IFN-gamma, but not IL-4. Microparticles surface-modified for GM-CSF release were prepared from either PG-MP or PG pre-treated with poly-L-lysine (PG-Lys) to manipulate surface charge. GM-CSF released from PG-Lys-MP was observed for up to 26 days. The biologic activity of released GM-CSF was confirmed by using a h-GM-CSF-dependent cell line. The efficacy of the alpha-cd3/cd28-MP and GMCSF-MP was studied in a syngeneic mouse tumor prevention and regression model. Co-injection of Meth A fibrosarcoma cells with alpha-cd3/cd28-MP and GMCSF-MP completely prevented tumor implantation (0/24). The regression model showed complete tumor regression in four of seven animals and stable disease in three of seven. In the latter study, a dramatic level of DC infiltration was observed compared to controls.

Authors : Shalaby Waleed S W , Yeh Heidi , Woo Edward , Hendren Samantha , Corbett Joel T , Gray Heidi , June Carl H , Shalaby Shalaby W ,

Related products :

Catalog number Product name Quantity
EIAAB43542 hD55,Homo sapiens,Human,Testis development protein NYD-SP25,TPD52L3,Tumor protein D52-like 3,Tumor protein D55
K055 P53 (human) under development , TUMOR - MARKERS, conventional PCR 100 REACTIONS
30-281 MLSTD1 catalyzes the reduction of fatty acyl-CoA to fatty alcohols. The preferred substrates are C16, C18, C18 1 and C18 2 but low activity can be observed with C10-C14 substrates. 0.05 mg
CUST-PROD Custom Immunoassay Development Program Assay Development
26-671 DPPA2 may play a role in maintaining cell pluripotentiality. ECSA_DPPA2 is a promising target for antigen-specific immunotherapy in non-small cell lung cancers. 0.05 mg
29-740 When FAM107A is transfected into cell lines in which it is not expressed, it suppresses cell growth. It may play a role in tumor development. 0.1 mg
27-805 ODAG (Ocular development-associated gene), a novel transcription factor located on chromosome 7, encodes a protein that may play a role in eye development. mRNA profiling in multiple human tissue indi 0.05 mg
27-255 Homeobox-containing genes are thought to have a role in controlling development. In Drosophila, the 'engrailed' (en) gene plays an important role during development in segmentation, where it is requir 0.05 mg
SL10020B Human ELISpot Development Sets Human Granulocyte Macrophage- Colony Stimulating Factor (GM-CSF) Development Set for ELISpot 5 x 96 wells
SL10009B Human ELISpot Development Sets Human Monocyte Chemotactic Activating Factor (MCAF) Development Set for ELISpot 5 x 96 wells
SL10024B Human ELISpot Development Sets Human Interferon-Gamma (IFN-y) Development Set for ELISpot 5 x 96 wells
27-649 HIon Channel1 is a transcriptional repressor. HIon Channel1 may act as a tumor suppressor. HIon Channel1 may be involved in development of head, face, limbs and ventral body wall. Defects in HIon Chan 0.05 mg
SL10008B Human ELISpot Development Sets Human Interleukin-8 (IL-8) Development Set for ELISpot 5 x 96 wells
30-323 NPNT is a functional ligand of integrin alpha-8_beta-1 in kidney development. It regulates with integrin alpha-8_beta-1 the expression of GDNF which is essential for kidney development. It may also pl 0.05 mg
RP20211-1 HCV NS3 Protease Substrates 1 1,0mg
SUB-ATF2-010 Substrates: ATF-2 , protein 10
RP20209 Caspase_1 Substrates 1 5mg
RP20209-1 Caspase-1 Substrates 1 1,0mg
PEP-ELK1-010 Substrates: ELK-1 , protein 10
42R-TB100x TMB for Precipitation , Substrates 500 ml
RP20211 HCV NS3 Protease Substrates 1 5mg
RP20209 Caspase_1 Substrates 1 1mg
RP20209 Caspase_1 Substrates 1 25mg
RP20211 HCV NS3 Protease Substrates 1 1mg
RP20214-1 Casein Kinase Substrates 3 1,0mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur